The SEMAFOOT2 Pilot. Effect of semaglutide on healing of foot ulcers in type 2 diabetes patients. A Pilot study.

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504913-65-01

Acronym

CODIF-015

Enrollment

100

Registered

2025-06-15

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes, Diabetic foot ulcer

Brief summary

Proportion of index ulcers completely healed after 20 weeks of intervention

Detailed description

Change in ulcer area from time of randomization until after 20 weeks of intervention

Interventions

DRUGOzempic 1 mg solution for injection in pre-filled pen

DRUGOzempic 0.5 mg solution for injection in pre-filled pen

DRUGOzempic 0.25 mg solution for injection in pre-filled pen

DRUGBlinded to the test product

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Proportion of index ulcers completely healed after 20 weeks of intervention	—

Secondary

Measure	Time frame
Change in ulcer area from time of randomization until after 20 weeks of intervention	—

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026